May 11, 2020
The Ohio State University’s Office of Research announced details of the final round of funding to boost research in response to the COVID-19 pandemic, including research from the College of Pharmacy.
Dan Shu, PhD, research associate professor in the Division of Pharmaceutics and Pharmacology, is leading a project to develop a rapid, convenient and low-cost alternative for the early diagnosis of COVID-19 through the detection of the SARS-CoV-2 antigen.
Dr. Shu’s project, “Rapid, simple, and low-cost for early diagnosis of COVID-19 by nuclei acid probes on nitrocellulose membrane without the need of other equipment,” is one of 11 additional projects that were awarded funding for a total of $310,000. Through three rounds of funding, 24 projects were awarded over $770,000 from the Office of Research.
“We are so proud of Dr. Shu and her team,” said Sharyn Baker, PharmD, PhD, Gertrude Parker Heer Chair in Cancer Research, professor of Pharmaceutics and Hematology and chair of the college’s Division of Pharmaceutics and Pharmaceutical Chemistry. “This is exactly the kind of work we’re producing in the division, and Dr. Shu’s project will help us advance our mission.”